Algert Global LLC Celldex Therapeutics, Inc. Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 104,337 shares of CLDX stock, worth $2.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

104,337

Previous 54,983 89.76%

Holding current value

$2.2 Million

Previous $1.87 Million 41.09%

% of portfolio

0.06%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$23.31 - $32.4 $1.15 Million - $1.6 Million	49,354 Added 89.76%	104,337 $2.64 Million
Q3 2024 Nov 12, 2024	SELL	$32.06 - $44.56 $661,429 - $919,317	-20,631 Reduced 27.28%	54,983 $1.87 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $1.07 Million - $1.39 Million	32,564 Added 75.64%	75,614 $2.8 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $1.17 Million - $1.72 Million	33,140 Added 334.41%	43,050 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $427,781 - $769,098	-18,920 Reduced 65.63%	9,910 $393,000
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $271,042 - $398,949	-10,650 Reduced 26.98%	28,830 $793,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $479,914 - $606,508	15,844 Added 67.03%	39,480 $1.34 Million
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $533,629 - $727,718	15,343 Added 185.01%	23,636 $850,000
Q4 2022 Feb 13, 2023	SELL	$27.78 - $45.38 $409,477 - $668,901	-14,740 Reduced 64.0%	8,293 $370,000
Q3 2022 Nov 15, 2022	BUY	$22.7 - $37.57 $95,067 - $157,343	4,188 Added 22.22%	23,033 $647,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $99,630 - $181,423	4,860 Added 34.75%	18,845 $508,000
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $187,952 - $267,376	6,800 Added 94.64%	13,985 $476,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $34,609 - $54,581	-970 Reduced 11.89%	7,185 $278,000
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $236,087 - $456,598	8,155 New	8,155 $440,000
Q1 2021 May 14, 2021	SELL	$16.19 - $29.91 $177,766 - $328,411	-10,980 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $511,009 - $775,547	-34,090 Reduced 75.64%	10,980 $192,000
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $434,925 - $684,613	45,070 New	45,070 $668,000

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $987M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Celldex Therapeutics, Inc. Transaction History